Blog

A month has gone by since the last earnings report for Verizon Communications (VZ). Shares have added about 2.7% in that time frame, underperforming the S&P 500.

But investors have to be wondering

It has been about a month since the last earnings report for Solaris Energy Infrastructure, Inc. (SEI). Shares have added about 1.3% in that time frame, underperforming the S&P 500.

Will the recent

A month has gone by since the last earnings report for Nucor (NUE). Shares have added about 6.7% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to

It has been about a month since the last earnings report for Sanmina (SANM). Shares have added about 20.7% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue

It has been about a month since the last earnings report for Nov Inc. (NOV). Shares have added about 4.1% in that time frame, underperforming the S&P 500.

Will the recent positive trend continue

It has been about a month since the last earnings report for Brown & Brown (BRO). Shares have lost about 9.7% in that time frame, underperforming the S&P 500.

But investors have to be wondering

It has been about a month since the last earnings report for Celestica (CLS). Shares have added about 2.6% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will

A month has gone by since the last earnings report for Domino's Pizza (DPZ). Shares have lost about 8.8% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the

It has been about a month since the last earnings report for Cincinnati Financial (CINF). Shares have added about 1.3% in that time frame, underperforming the S&P 500.

Will the recent positive trend

It has been about a month since the last earnings report for Cadence Design Systems (CDNS). Shares have added about 17.4% in that time frame, outperforming the S&P 500.

Will the recent positive

It has been about a month since the last earnings report for Alexandria Real Estate Equities (ARE). Shares have added about 20% in that time frame, outperforming the S&P 500.

But investors have to

A month has gone by since the last earnings report for Ares Capital (ARCC). Shares have lost about 0.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

It has been about a month since the last earnings report for Amkor Technology (AMKR). Shares have added about 2.9% in that time frame, underperforming the S&P 500.

But investors have to be

Westinghouse Air Brake Technologies WAB, operating as Wabtec, has seen its top line bolstered by robust backlog growth, enhancing the company’s overall performance. Shareholder-friendly initiatives

USA Rare Earth, Inc. USAR remains in the early stages of commercial growth and continues to face losses as operations scale. While revenue generation has started following the acquisition of Less

Investors in LifeVantage Corporation LFVN need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $15.00 Call had some of the highest

Arthur J. Gallagher & Co. AJG continues to expand its specialty insurance capabilities through the acquisition of Twin Elms, a Florida-based retail insurance broker specializing in environmental

Growing aircraft deliveries worldwide, expanding airline fleet and rising demand for maintenance, repair and overhaul (MRO) services continue to support growth in the aviation services space. A

Capri Holdings Limited CPRI delivered fourth-quarter fiscal 2026 results, with revenues missing the Zacks Consensus Estimate and declining year over year. However, earnings surpassed the consensus

SoundHound AI, Inc.’s SOUN automotive and IoT business showed strong organic momentum in the first quarter of 2026, with revenues surging 88% year over year, excluding acquisitions. This growth

Black Diamond Therapeutics BDTX is widening the opportunity set for silevertinib by pushing beyond lung cancer and into glioblastoma, a move that leans on the same core attribute that has driven

Black Diamond Therapeutics BDTX delivered a modest first-quarter earnings beat, but the stock’s story remains almost entirely clinical. Investors are underwriting one main question: can silevertinib

Shopify Inc. SHOP and Amazon.com, Inc. AMZN are two leading companies shaping the next phase of AI-driven commerce, but they are approaching the opportunity from distinct directions. Shopify is

Black Diamond Therapeutics BDTX is building its equity story around one drug, silevertinib, a brain-penetrant, fourth-generation EGFR inhibitor being studied in EGFR–mutant non-small cell lung

Cardinal Health CAH and Cencora COR remain central players in pharmaceutical distribution, but their growth strategies are increasingly defined by specialty expansion and higher-margin health care